Among immunomodulatory and antimicrobial therapies that can influence the host immune system, the low-virulence and the biofilm-forming properties of organisms may be one of the causes why the sensitivity of serum CRP is low in diagnosing PJI. Here, CRP is linked to juvenile polyposis syndrome.